IdentificationGeneric Name(2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-olDrugBank Accession NumberDB04776BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-2-({6-[benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)butan-1-ol (DB04776)× CloseWeightAverage: 368.4759 Monoisotopic: 368.232459548 Chemical FormulaC20H28N6OSynonyms(2R)-2-({6-[Benzyl(methyl)amino]-9-isopropyl-9H-purin-2-yl}amino)-1-butanolAftin-4PharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUPyridoxal kinaseNot AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesHeterocyclic Compounds, Fused-Ring
PurinesChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as 6-alkylaminopurines. These are compounds that contain an alkylamine group attached at the 6-position of a purine. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring.KingdomOrganic compoundsSuper ClassOrganoheterocyclic compoundsClassImidazopyrimidinesSub ClassPurines and purine derivativesDirect Parent6-alkylaminopurinesAlternative ParentsDialkylarylamines / Benzylamines / Secondary alkylarylamines / Aminopyrimidines and derivatives / N-substituted imidazoles / Imidolactams / Heteroaromatic compounds / Azacyclic compounds / Primary alcohols / Organopnictogen compounds / Hydrocarbon derivatives


 show 1 moreSubstituents6-alkylaminopurine / Alcohol / Amine / Aminopyrimidine / Aromatic heteropolycyclic compound / Azacycle / Azole / Benzenoid / Benzylamine / Dialkylarylamine / Heteroaromatic compound / Hydrocarbon derivative / Imidazole / Imidolactam / Monocyclic benzene moiety / N-substituted imidazole / Organic nitrogen compound / Organic oxygen compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Primary alcohol / Pyrimidine / Secondary aliphatic/aromatic amine / Secondary amine


 show 15 moreMolecular FrameworkAromatic heteropolycyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyYPYWONAECUVKHY-MRXNPFEDSA-NInChIInChI=1S/C20H28N6O/c1-5-16(12-27)22-20-23-18(25(4)11-15-9-7-6-8-10-15)17-19(24-20)26(13-21-17)14(2)3/h6-10,13-14,16,27H,5,11-12H2,1-4H3,(H,22,23,24)/t16-/m1/s1IUPAC Name(2R)-2-({6-[benzyl(methyl)amino]-9-(propan-2-yl)-9H-purin-2-yl}amino)butan-1-olSMILES[H][C@@](CC)(CO)NC1=NC2=C(N=CN2C(C)C)C(=N1)N(C)CC1=CC=CC=C1ReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound5289296PubChem Substance46506238ChemSpider4451290BindingDB10909ChEMBLCHEMBL1235702ZINCZINC000012504508PDBe LigandRMCPDB Entries1ygjClinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility0.24 mg/mLALOGPSlogP3.45ALOGPSlogP3.53ChemaxonlogS-3.2ALOGPSpKa (Strongest Acidic)14.32ChemaxonpKa (Strongest Basic)5.06ChemaxonPhysiological Charge0ChemaxonHydrogen Acceptor Count6ChemaxonHydrogen Donor Count2ChemaxonPolar Surface Area79.1 Å2ChemaxonRotatable Bond Count8ChemaxonRefractivity110.38 m3·mol-1ChemaxonPolarizability42.15 Å3ChemaxonNumber of Rings3ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleYesChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption+1.0Blood Brain Barrier-0.5345Caco-2 permeable-0.5799P-glycoprotein substrateSubstrate0.8705P-glycoprotein inhibitor INon-inhibitor0.8153P-glycoprotein inhibitor IINon-inhibitor0.9217Renal organic cation transporterNon-inhibitor0.7503CYP450 2C9 substrateNon-substrate0.8463CYP450 2D6 substrateNon-substrate0.7628CYP450 3A4 substrateNon-substrate0.5059CYP450 1A2 substrateInhibitor0.77CYP450 2C9 inhibitorInhibitor0.5665CYP450 2D6 inhibitorInhibitor0.7374CYP450 2C19 inhibitorNon-inhibitor0.9045CYP450 3A4 inhibitorNon-inhibitor0.7282CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9172Ames testNon AMES toxic0.5774CarcinogenicityNon-carcinogens0.8847BiodegradationNot ready biodegradable0.9727Rat acute toxicity2.7053 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.7587hERG inhibition (predictor II)Non-inhibitor0.5529  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Pyridoxal kinaseKindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionZinc ion bindingSpecific FunctionRequired for synthesis of pyridoxal-5-phosphate from vitamin B6.Gene NamePDXKUniprot IDO00764Uniprot NamePyridoxal kinaseMolecular Weight35102.105 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 11, 2007 17:49 / Updated at June 12, 2020 16:52 